| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stomach Neoplasms | 48 | 2024 | 192 | 7.030 |
Why?
|
| Helicobacter pylori | 19 | 2024 | 105 | 2.810 |
Why?
|
| Helicobacter Infections | 14 | 2024 | 74 | 2.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 23 | 2022 | 781 | 1.410 |
Why?
|
| MicroRNAs | 10 | 2022 | 386 | 1.110 |
Why?
|
| Apoptosis | 14 | 2022 | 1317 | 1.100 |
Why?
|
| Colonoscopy | 4 | 2019 | 98 | 1.030 |
Why?
|
| Colonic Neoplasms | 7 | 2011 | 181 | 1.020 |
Why?
|
| Adenoma | 7 | 2013 | 89 | 1.020 |
Why?
|
| Adenocarcinoma | 7 | 2018 | 239 | 1.010 |
Why?
|
| Peptide Hormones | 7 | 2020 | 19 | 0.980 |
Why?
|
| Colorectal Neoplasms | 12 | 2019 | 413 | 0.970 |
Why?
|
| Cell Line, Tumor | 36 | 2022 | 2128 | 0.940 |
Why?
|
| Gastric Mucosa | 10 | 2023 | 50 | 0.900 |
Why?
|
| Neoplasm Proteins | 7 | 2019 | 203 | 0.900 |
Why?
|
| Carcinoma | 3 | 2024 | 94 | 0.750 |
Why?
|
| Humans | 82 | 2024 | 34853 | 0.700 |
Why?
|
| Cell Proliferation | 22 | 2022 | 1149 | 0.700 |
Why?
|
| Peptide Library | 1 | 2018 | 25 | 0.650 |
Why?
|
| Epithelial Cells | 9 | 2021 | 366 | 0.640 |
Why?
|
| Repressor Proteins | 4 | 2021 | 226 | 0.640 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 63 | 0.630 |
Why?
|
| Patient Compliance | 2 | 2019 | 202 | 0.610 |
Why?
|
| Peptide Fragments | 1 | 2018 | 298 | 0.560 |
Why?
|
| Endoscopy | 1 | 2014 | 15 | 0.510 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 19 | 0.510 |
Why?
|
| Nuclear Proteins | 8 | 2023 | 287 | 0.490 |
Why?
|
| Histones | 3 | 2017 | 177 | 0.470 |
Why?
|
| Stomach | 4 | 2020 | 43 | 0.440 |
Why?
|
| Down-Regulation | 6 | 2021 | 420 | 0.440 |
Why?
|
| District of Columbia | 5 | 2014 | 68 | 0.430 |
Why?
|
| Crohn Disease | 4 | 2021 | 55 | 0.410 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2022 | 200 | 0.410 |
Why?
|
| Antigens, Bacterial | 7 | 2019 | 129 | 0.410 |
Why?
|
| DNA Methylation | 7 | 2014 | 301 | 0.410 |
Why?
|
| Female | 38 | 2021 | 19873 | 0.410 |
Why?
|
| Aged | 22 | 2021 | 6448 | 0.410 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 2333 | 0.400 |
Why?
|
| Mitochondria | 2 | 2019 | 454 | 0.400 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 756 | 0.400 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 81 | 0.380 |
Why?
|
| Male | 35 | 2021 | 18870 | 0.380 |
Why?
|
| Proteomics | 6 | 2021 | 302 | 0.380 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 124 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 355 | 0.370 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 128 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 176 | 0.360 |
Why?
|
| Autophagy | 3 | 2022 | 111 | 0.360 |
Why?
|
| Middle Aged | 24 | 2019 | 9642 | 0.360 |
Why?
|
| alpha-Defensins | 2 | 2021 | 15 | 0.360 |
Why?
|
| Carcinoma in Situ | 1 | 2009 | 13 | 0.350 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 69 | 0.350 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2008 | 7 | 0.350 |
Why?
|
| Retrospective Studies | 7 | 2021 | 1961 | 0.340 |
Why?
|
| Mice | 17 | 2024 | 5668 | 0.340 |
Why?
|
| Transcription Factors | 4 | 2023 | 653 | 0.340 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 52 | 0.330 |
Why?
|
| Carrier Proteins | 6 | 2019 | 287 | 0.320 |
Why?
|
| Lysosomes | 2 | 2019 | 80 | 0.320 |
Why?
|
| Bacterial Proteins | 7 | 2019 | 520 | 0.310 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 480 | 0.310 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 33 | 0.310 |
Why?
|
| Colonic Polyps | 3 | 2014 | 67 | 0.300 |
Why?
|
| Microsatellite Instability | 5 | 2011 | 43 | 0.290 |
Why?
|
| Mutation | 4 | 2023 | 1023 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2022 | 184 | 0.280 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2018 | 180 | 0.280 |
Why?
|
| Animals | 21 | 2024 | 14307 | 0.280 |
Why?
|
| Lymphatic Metastasis | 3 | 2021 | 63 | 0.280 |
Why?
|
| Colon | 2 | 2021 | 98 | 0.270 |
Why?
|
| Fluorouracil | 1 | 2005 | 32 | 0.270 |
Why?
|
| Aspirin | 1 | 2005 | 45 | 0.260 |
Why?
|
| Cell Movement | 8 | 2021 | 545 | 0.260 |
Why?
|
| Neoplasm Staging | 6 | 2021 | 269 | 0.250 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2024 | 4 | 0.250 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2024 | 15 | 0.240 |
Why?
|
| Adenosine | 1 | 2024 | 54 | 0.240 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2003 | 11 | 0.240 |
Why?
|
| Signal Transduction | 6 | 2019 | 1802 | 0.230 |
Why?
|
| Colitis, Ulcerative | 2 | 2021 | 49 | 0.230 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 600 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 484 | 0.220 |
Why?
|
| Histone Deacetylase 1 | 2 | 2020 | 14 | 0.220 |
Why?
|
| Cell Line | 7 | 2021 | 1289 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2021 | 3 | 0.210 |
Why?
|
| Naphthalimides | 1 | 2021 | 3 | 0.210 |
Why?
|
| Immunohistochemistry | 6 | 2018 | 859 | 0.210 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 80 | 0.210 |
Why?
|
| Acetylation | 4 | 2020 | 94 | 0.210 |
Why?
|
| Mass Screening | 2 | 2019 | 427 | 0.210 |
Why?
|
| Benzimidazoles | 1 | 2021 | 36 | 0.200 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2020 | 41 | 0.200 |
Why?
|
| Exosomes | 2 | 2020 | 97 | 0.200 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2020 | 10 | 0.200 |
Why?
|
| Enterotoxins | 1 | 2021 | 32 | 0.200 |
Why?
|
| Organoids | 1 | 2021 | 20 | 0.200 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2020 | 12 | 0.190 |
Why?
|
| Hedgehog Proteins | 1 | 2021 | 45 | 0.190 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 25 | 0.190 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 58 | 0.190 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2019 | 146 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 242 | 0.190 |
Why?
|
| Adult | 14 | 2018 | 11034 | 0.190 |
Why?
|
| beta Catenin | 1 | 2020 | 46 | 0.190 |
Why?
|
| Disease Progression | 4 | 2021 | 580 | 0.190 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2020 | 9 | 0.190 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 522 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 185 | 0.190 |
Why?
|
| Up-Regulation | 4 | 2019 | 490 | 0.190 |
Why?
|
| Cannabidiol | 1 | 2019 | 3 | 0.180 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 10 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 445 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 5 | 2020 | 649 | 0.180 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 34 | 0.180 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 86 | 0.180 |
Why?
|
| Iridoids | 1 | 2019 | 5 | 0.180 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 6 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2019 | 5 | 0.180 |
Why?
|
| Cell Survival | 5 | 2019 | 818 | 0.180 |
Why?
|
| Gastritis, Atrophic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2019 | 12 | 0.170 |
Why?
|
| Outpatients | 2 | 2019 | 33 | 0.170 |
Why?
|
| Cholecalciferol | 1 | 2019 | 19 | 0.170 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 96 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 5 | 2019 | 247 | 0.170 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2009 | 23 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 85 | 0.170 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 396 | 0.160 |
Why?
|
| DNA Damage | 1 | 2020 | 341 | 0.160 |
Why?
|
| STAT Transcription Factors | 1 | 2017 | 10 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 52 | 0.160 |
Why?
|
| Mice, Nude | 4 | 2020 | 323 | 0.160 |
Why?
|
| Janus Kinases | 1 | 2017 | 19 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 97 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2018 | 154 | 0.150 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2016 | 9 | 0.150 |
Why?
|
| Hydrazines | 1 | 2016 | 21 | 0.150 |
Why?
|
| NF-kappa B | 3 | 2015 | 306 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2017 | 235 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 292 | 0.150 |
Why?
|
| Transfection | 4 | 2019 | 496 | 0.140 |
Why?
|
| Age Factors | 2 | 2009 | 1007 | 0.140 |
Why?
|
| Curcumin | 1 | 2016 | 66 | 0.140 |
Why?
|
| Receptors, Calcitriol | 2 | 2019 | 59 | 0.140 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 217 | 0.130 |
Why?
|
| Gastrins | 1 | 2015 | 9 | 0.130 |
Why?
|
| Case-Control Studies | 6 | 2018 | 1056 | 0.130 |
Why?
|
| Microsatellite Repeats | 2 | 2005 | 51 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 89 | 0.120 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 42 | 0.120 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2014 | 4 | 0.120 |
Why?
|
| Gene Dosage | 1 | 2014 | 74 | 0.120 |
Why?
|
| CpG Islands | 1 | 2014 | 91 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2012 | 528 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 162 | 0.120 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 30 | 0.120 |
Why?
|
| Hospitals | 1 | 2014 | 86 | 0.120 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2012 | 5 | 0.120 |
Why?
|
| Risk Factors | 5 | 2014 | 3414 | 0.120 |
Why?
|
| United States | 4 | 2022 | 3894 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 638 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2014 | 122 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2024 | 1152 | 0.110 |
Why?
|
| Homeostasis | 1 | 2014 | 172 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2012 | 30 | 0.110 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 29 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 2 | 2013 | 92 | 0.110 |
Why?
|
| Amino Acids | 1 | 2013 | 139 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2012 | 49 | 0.110 |
Why?
|
| Ribonucleoproteins | 1 | 2012 | 29 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 968 | 0.110 |
Why?
|
| Quercetin | 1 | 2012 | 41 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2024 | 97 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 58 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 1033 | 0.110 |
Why?
|
| Metaplasia | 2 | 2023 | 34 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 133 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 161 | 0.100 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Gene Fusion | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 30 | 0.100 |
Why?
|
| Butyrates | 1 | 2011 | 31 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 874 | 0.100 |
Why?
|
| Complement C9 | 1 | 2010 | 2 | 0.100 |
Why?
|
| Alpha-Globulins | 1 | 2010 | 3 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 59 | 0.100 |
Why?
|
| Oncogenes | 2 | 2020 | 43 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2012 | 360 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1003 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 1530 | 0.090 |
Why?
|
| Proteins | 1 | 2013 | 352 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2024 | 167 | 0.090 |
Why?
|
| Biopsy | 3 | 2017 | 151 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 286 | 0.090 |
Why?
|
| Chromosomal Instability | 2 | 2010 | 21 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 2009 | 23 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2009 | 229 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 569 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 2 | 2024 | 179 | 0.090 |
Why?
|
| Rectum | 1 | 2009 | 22 | 0.090 |
Why?
|
| Vitamin D | 1 | 2011 | 176 | 0.090 |
Why?
|
| Sex Factors | 2 | 2009 | 859 | 0.090 |
Why?
|
| Nuclear Envelope | 1 | 2008 | 9 | 0.090 |
Why?
|
| Proteome | 1 | 2010 | 132 | 0.090 |
Why?
|
| Cell Fractionation | 1 | 2008 | 28 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 74 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2012 | 486 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2008 | 61 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 49 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 964 | 0.080 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 220 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2008 | 170 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2020 | 322 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2008 | 135 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 193 | 0.080 |
Why?
|
| DNA Mismatch Repair | 1 | 2008 | 24 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2021 | 878 | 0.080 |
Why?
|
| Chi-Square Distribution | 3 | 2013 | 213 | 0.080 |
Why?
|
| Duodenal Ulcer | 1 | 2006 | 5 | 0.070 |
Why?
|
| Peptic Ulcer | 1 | 2006 | 9 | 0.070 |
Why?
|
| Penicillins | 1 | 2006 | 12 | 0.070 |
Why?
|
| Prevalence | 1 | 2011 | 1425 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1681 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 136 | 0.070 |
Why?
|
| Computational Biology | 2 | 2021 | 275 | 0.070 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 65 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 72 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2018 | 897 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1300 | 0.070 |
Why?
|
| Stomach Ulcer | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 166 | 0.060 |
Why?
|
| Gastritis | 1 | 2004 | 11 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2012 | 834 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 139 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2024 | 33 | 0.060 |
Why?
|
| Virus Activation | 1 | 2024 | 35 | 0.060 |
Why?
|
| Ceramides | 1 | 2024 | 41 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 391 | 0.060 |
Why?
|
| MutS Homolog 2 Protein | 3 | 2009 | 30 | 0.060 |
Why?
|
| Catalase | 1 | 2024 | 106 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 25 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 211 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 416 | 0.060 |
Why?
|
| Iran | 3 | 2009 | 183 | 0.060 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2022 | 4 | 0.060 |
Why?
|
| Peptide Termination Factors | 1 | 2022 | 3 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 106 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2015 | 309 | 0.060 |
Why?
|
| Vimentin | 1 | 2022 | 32 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 95 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 984 | 0.050 |
Why?
|
| Isotope Labeling | 2 | 2013 | 27 | 0.050 |
Why?
|
| Genomics | 1 | 2023 | 201 | 0.050 |
Why?
|
| Tennessee | 1 | 2022 | 59 | 0.050 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 17 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2021 | 30 | 0.050 |
Why?
|
| Mucin-6 | 1 | 2021 | 6 | 0.050 |
Why?
|
| Helicobacter felis | 1 | 2021 | 2 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 99 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 133 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2021 | 350 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1442 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 140 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2021 | 88 | 0.050 |
Why?
|
| Pinocytosis | 1 | 2020 | 8 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 255 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2020 | 143 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 132 | 0.050 |
Why?
|
| Protein Binding | 2 | 2014 | 913 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 36 | 0.050 |
Why?
|
| Integrins | 1 | 2020 | 49 | 0.050 |
Why?
|
| Calcium | 2 | 2019 | 445 | 0.050 |
Why?
|
| Cathartics | 1 | 2019 | 6 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 173 | 0.050 |
Why?
|
| Haplotypes | 2 | 2012 | 152 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2019 | 31 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 1353 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 43 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 198 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 71 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 80 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2019 | 39 | 0.040 |
Why?
|
| Acetylglucosaminidase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cathelicidins | 1 | 2019 | 2 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2019 | 9 | 0.040 |
Why?
|
| Acid Phosphatase | 1 | 2019 | 19 | 0.040 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2019 | 7 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1124 | 0.040 |
Why?
|
| Cell Death | 1 | 2020 | 260 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 76 | 0.040 |
Why?
|
| Universities | 1 | 2022 | 363 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 53 | 0.040 |
Why?
|
| Oman | 2 | 2008 | 6 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 882 | 0.040 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2019 | 33 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 89 | 0.040 |
Why?
|
| Clathrin | 1 | 2018 | 19 | 0.040 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 642 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 17 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 142 | 0.040 |
Why?
|
| Microbial Viability | 1 | 2018 | 35 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 894 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 2012 | 57 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 19 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2017 | 27 | 0.040 |
Why?
|
| Muramidase | 1 | 2017 | 18 | 0.040 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2017 | 18 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 104 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 122 | 0.040 |
Why?
|
| Triazoles | 1 | 2018 | 85 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2017 | 121 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 376 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 184 | 0.040 |
Why?
|
| Protein Transport | 1 | 2018 | 286 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 211 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 145 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 342 | 0.040 |
Why?
|
| Cobalt | 1 | 2016 | 23 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 87 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 126 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 150 | 0.040 |
Why?
|
| Solubility | 1 | 2016 | 115 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 115 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 117 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 641 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 282 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 181 | 0.030 |
Why?
|
| Mucins | 2 | 2008 | 33 | 0.030 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2015 | 9 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 2015 | 13 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 751 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 41 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2005 | 29 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adolescent | 3 | 2012 | 5035 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 62 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 72 | 0.030 |
Why?
|
| Proprotein Convertases | 1 | 2013 | 8 | 0.030 |
Why?
|
| Mannose-Binding Lectins | 1 | 2013 | 14 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 36 | 0.030 |
Why?
|
| Isoelectric Focusing | 1 | 2012 | 16 | 0.030 |
Why?
|
| Gastroscopy | 1 | 2012 | 7 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 195 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1534 | 0.030 |
Why?
|
| Anilides | 1 | 2012 | 27 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 151 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 88 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2012 | 10 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2012 | 12 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2012 | 171 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2011 | 9 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 707 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 49 | 0.030 |
Why?
|
| Seasons | 1 | 2011 | 112 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2011 | 25 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 406 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 528 | 0.020 |
Why?
|
| Densitometry | 1 | 2010 | 13 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 45 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 87 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3261 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 138 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2010 | 65 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 67 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 932 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 517 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 31 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2011 | 213 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 605 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2009 | 9 | 0.020 |
Why?
|
| Genes, APC | 1 | 2009 | 14 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 44 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 298 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2008 | 66 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 555 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 284 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 901 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 570 | 0.020 |
Why?
|
| Aging | 1 | 2011 | 639 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 269 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 430 | 0.020 |
Why?
|
| Phospholipases A | 1 | 2003 | 8 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2003 | 8 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 19 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2003 | 42 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 296 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 562 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4012 | 0.010 |
Why?
|